- Home
- OSW vs BLTE Comparison
OSW vs BLTE Comparison
Compare OSW & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSW
- BLTE
- Stock Information
- Founded
- OSW 2017
- BLTE 2018
- Country
- OSW Bahamas
- BLTE United States
- Employees
- OSW N/A
- BLTE N/A
- Industry
- OSW Hotels/Resorts
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- OSW Consumer Discretionary
- BLTE Health Care
- Exchange
- OSW Nasdaq
- BLTE Nasdaq
- Market Cap
- OSW 1.8B
- BLTE 1.9B
- IPO Year
- OSW N/A
- BLTE 2022
- Fundamental
- Price
- OSW $18.74
- BLTE $61.10
- Analyst Decision
- OSW Strong Buy
- BLTE Strong Buy
- Analyst Count
- OSW 5
- BLTE 4
- Target Price
- OSW $19.60
- BLTE $96.67
- AVG Volume (30 Days)
- OSW 709.5K
- BLTE 29.7K
- Earning Date
- OSW 04-30-2025
- BLTE 05-14-2025
- Dividend Yield
- OSW 0.85%
- BLTE N/A
- EPS Growth
- OSW 84.76
- BLTE N/A
- EPS
- OSW 0.63
- BLTE N/A
- Revenue
- OSW $903,423,000.00
- BLTE N/A
- Revenue This Year
- OSW $7.70
- BLTE N/A
- Revenue Next Year
- OSW $8.41
- BLTE N/A
- P/E Ratio
- OSW $29.75
- BLTE N/A
- Revenue Growth
- OSW 9.80
- BLTE N/A
- 52 Week Low
- OSW $14.21
- BLTE $40.00
- 52 Week High
- OSW $23.01
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- OSW 61.08
- BLTE 51.45
- Support Level
- OSW $17.85
- BLTE $59.04
- Resistance Level
- OSW $19.12
- BLTE $62.55
- Average True Range (ATR)
- OSW 0.67
- BLTE 2.51
- MACD
- OSW 0.23
- BLTE 0.32
- Stochastic Oscillator
- OSW 87.18
- BLTE 74.06
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.